Geriatric Pharmacology: Safe Prescribing & Beers Criteria

Added:

Aging Drug Effects
Anticholinergic Risks
PPI and Drug Risks
Delirium and Cramps
Benzodiazepine Harms
Beers and Start
Anticoagulant Choice
UTI Management
Pain and Behaviors
Diabetes and Hormones

Aging Drug Effects

0:00
Playing Section
  • 1

    Absorption is least affected by aging, but distribution, metabolism, and elimination decline significantly.

  • 2

    Water-soluble drugs have reduced distribution due to lower body water and muscle mass.

  • 3

    Fat-soluble drugs are stored longer and release over extended periods in older adults.

Basic principles of pharmacokinetics and pharmacodynamics (ADME processes) in a standard adult population.
Normal physiological changes associated with the aging process, particularly renal, hepatic, and cardiovascular decline.
The clinical concept of polypharmacy and the general mechanisms underlying drug-drug and drug-disease interactions.
Familiarity with common chronic conditions in older adults, such as cognitive impairment, hypertension, osteoarthritis, and sensory deficits.
Clinical application of the STOPP/START criteria as a companion tool to the Beers Criteria for medication optimization.
Structured protocols for safe deprescribing, including tapering schedules for high-risk medications like benzodiazepines and proton pump inhibitors.
Designing non-pharmacological management plans for common geriatric syndromes, such as chronic insomnia, anxiety, and behavioral symptoms of dementia.
Analyzing complex patient case studies featuring multimorbidity to balance guideline-directed medical therapy with geriatric safety guidelines.
1.6K views27likes56:58@WIFamilyMedicineOriginal Release: 2019-05-10

In elderly patients, drug distribution is most significantly affected by aging due to decreased body water (from ~70% to 40-50%) and increased adipose tissue, while absorption remains relatively unchanged; therefore, healthcare providers should minimize anticholinergic medications (such as diphenhydramine, oxybutynin, paroxetine, and certain SSRIs) which disproportionately affect cognition and increase delirium risk, avoid NSAIDs and COX-2 inhibitors due to cardiovascular and renal risks, limit proton pump inhibitors to 8 weeks to prevent hypomagnesemia and osteoporosis, and consult evidence-based guidelines like the Beers Criteria to identify inappropriate medications and optimize prescribing safety in older adults.